Cart
sales@molnova.com
Tracheloside
CAS No. 33464-71-0
Tracheloside( —— )
Catalog No. M18434 CAS No. 33464-71-0
Tracheloside significantly decreases the activity of alkaline phosphatase (IC50: 0.31 μg/ml), a level of inhibition comparable to that of tamoxifen (IC50: 0.43 μg/ml).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 75 | In Stock |
|
| 2MG | 35 | In Stock |
|
| 5MG | 55 | In Stock |
|
| 10MG | 93 | In Stock |
|
| 25MG | 171 | In Stock |
|
| 50MG | 248 | In Stock |
|
| 100MG | 365 | In Stock |
|
| 200MG | 517 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTracheloside
-
NoteResearch use only, not for human use.
-
Brief DescriptionTracheloside significantly decreases the activity of alkaline phosphatase (IC50: 0.31 μg/ml), a level of inhibition comparable to that of tamoxifen (IC50: 0.43 μg/ml).
-
DescriptionTracheloside significantly decreases the activity of alkaline phosphatase (IC50: 0.31 μg/ml), a level of inhibition comparable to that of tamoxifen (IC50: 0.43 μg/ml).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptoralkaline phosphatase
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number33464-71-0
-
Formula Weight550.56
-
Molecular FormulaC27H34O12
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (181.64 mM)
-
SMILESO1C(=O)[C@@]([C@H](C1)Cc1cc(c(cc1)OC)OC)(Cc1cc(c(cc1)O[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O)O)O)CO)OC)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kitamura Y,et al. Cancer Lett. 2003 Oct 28;200(2):133-9.
molnova catalog
related products
-
Kizuta saponin K11
Kizuta saponin K11 is a saponin derived from Kalopanax pictum var. maximowiczii leaves, which is a widely used Korean medicinal plant.
-
C-DIM12
C-DIM12 increased expression of transfected human Nurr1, induced Nurr1 protein expression in primary dopaminergic neurons and enhanced neuronal survival from exposure to 6-OHDA.
-
SSAA09E3
SSAA09E3 is a novel inhibitor of SARS-CoV replication, acting by preventing fusion of the viral membrane with the host cellular membrane.
